Arca
Skip to content
Tools
Tools

PTGDR2: Prostaglandin D2 receptor 2

Receptor for prostaglandin D2 (PGD2).

  • Drugs that act on it: 16
  • Approved: 1
  • In phases 1 to 3: 15
  • Sponsors: 10

Who is on it, and how far along

Every drug ChEMBL records acting on PTGDR2, by the furthest stage it has reached for any use, coloured by modality.

How to read this

Each mark is one drug. Columns run from approved to phase 1; hover or tap a mark for its sponsor, modality and open trials, and click it to open the drug.

  • Small molecule 13
  • Other 3

Approved1

  • Ramatroban

Phase 33

  • Fevipiprant
  • Setipiprant
  • Timapiprant

Phase 28

  • ADC3680
  • ARRY-502
  • AZD1981
  • BI-671800
  • Donitriptan
  • MK-1029
  • QAV680
  • Vidupiprant

Phase 14

  • AM-211
  • AM-461
  • MK-7246
  • RG7185

Sponsors

Drugs on this target per company: the US application holder, else the industry sponsor leading the most of its trials.

The landscape

Every drug acting on it, furthest along first. The sponsor is the US application holder where there is one, else the industry lead sponsor of most of its registered trials. All act as: G protein-coupled receptor 44 antagonist.
RamatrobanApprovedKARE BiosciencesSmall moleculeAntagonist0
FevipiprantPhase 3Novartis PharmaceuticalsSmall moleculeAntagonist0
SetipiprantPhase 3Idorsia Pharmaceuticals Ltd.Small moleculeAntagonist0
TimapiprantPhase 3Chiesi FarmaceuticiSmall moleculeAntagonist0
ADC3680Phase 2Pulmagen TherapeuticsOtherAntagonist0
ARRY-502Phase 2PfizerSmall moleculeAntagonist0
AZD1981Phase 2AstraZeneca PharmaceuticalsSmall moleculeAntagonist0
BI-671800Phase 2Boehringer Ingelheim PharmaceuticalsSmall moleculeAntagonist0
DonitriptanPhase 2—Small moleculeAntagonist0
MK-1029Phase 2Merck & Co. (MSD)OtherAntagonist0
QAV680Phase 2Novartis PharmaceuticalsSmall moleculeAntagonist0
VidupiprantPhase 2AmgenSmall moleculeAntagonist0
AM-211Phase 1—Small moleculeAntagonist0
AM-461Phase 1—Small moleculeAntagonist0
MK-7246Phase 1—Small moleculeAntagonist0
RG7185Phase 1—OtherAntagonist0

Diseases most associated with it

Open Targets association score, 0 to 1; all associations

Drugs, mechanisms, furthest stage (max phase) and modality (molecule type) are from ChEMBL CHEMBL5071, ChEMBL 37, fetched 2026-11-18 (CC BY-SA 3.0). Sponsors are the US application holder (Drugs@FDA) for approved drugs with a US page, else the industry lead sponsor of the most of the drug's ClinicalTrials.gov trials. Open trials are recruiting or ongoing studies naming the drug as an intervention on ClinicalTrials.gov, checked daily; this page as of 2026-11-22. Gene name, function (UniProt Q9Y5Y4, CC BY 4.0) and disease associations are from Open Targets (CC0). ChEMBL and Open Targets

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.